Skip to main content

SPOT - Synthesis of Pretargeted Oncology Theranostics

Project description

Improvement of tumour-targeting specificity and treatment initialisation

Prompt cancer diagnosis and treatment initialisation are closely linked to disease outcome. The EU-funded SPOT project is developing an innovative approach for cancer imaging and treatment that exploits the combinatorial use of small antibody fragments and nanoparticles. The small antibody fragments, which exhibit highly specific targeting capacities and are capable of deep tissue penetration, will serve as guides for bioimaging and drug-delivering nanoparticles. Click reactions between moieties attached to small antibody fragments and nanoparticles ensure the specific visualisation of tumor tissue as well as delivery of nanoparticle payload at the tumour site. The SPOT approach is expected to overcome the limitations associated with the direct conjugation of drugs, imaging probes or drug-delivering nanoparticles to antibodies, offering an advanced strategy for tumour imaging and treatment. The approach also intents to achieve a crucial time gain between diagnosis and treatment initialisation.


Net EU contribution
€ 160 932,48
Avenida De Seneca 2
28040 Madrid

See on map

Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00